• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR

05/02/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment

Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Outside Sources, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

India Grants Pfizer Patent On Pneumonia Vaccine, Stokes Fear Of Unaffordability

22/08/2017 by Intellectual Property Watch Leave a Comment

MUMBAI (Reuters) – India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Asia/Pacific, Development, English, Health & IP, Outside Sources, Patents/Designs/Trade Secrets, Regional Policy

US Supreme Court Declines To Hear Biologic Drug Patent Fight

13/12/2016 by Intellectual Property Watch Leave a Comment

The US Supreme Court on Monday declined to hear a case over whether companies that make copycat versions of biologic drugs must wait six months after winning federal approval before bringing them to the market.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health & IP, IP Law, North America, Outside Sources, Patents/Designs/Trade Secrets, Regional Policy

A Comprehensive And Fair Solution To The Price Of Medicines

29/06/2016 by Intellectual Property Watch, Intellectual Property Watch 1 Comment

WHO’s Marie-Paule Kieny writes: Amid public outcry, political battles and media articles, no one seems to understand how, exactly, medicines prices are set. For years, pharmaceutical research companies have cited the large investment of time and resources that go into bringing a drug to market. More recently, they argue that their medicines are actually saving money by preventing expensive medical interventions like surgery and hospitalization.

But whatever the argument used, the price setting mechanisms for commodities that are inextricably linked to people’s health and survival must be made more transparent so that we can, as a global community, devise effective solutions.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Outside Sources, Patents/Designs/Trade Secrets, WHO

Washington Post- Colombia Battles World’s Biggest Drugmaker Over Cancer Drug

19/05/2016 by Intellectual Property Watch Leave a Comment

[From the Washington Post] BOGOTA, Colombia — Colombia’s government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Health & IP, Latin America/Caribbean, Lobbying, North America, Outside Sources, Patents/Designs/Trade Secrets, Regional Policy

Infojustice.org – Australian Commission Recommends Fair Use To Restore Balance In Copyright Law

03/05/2016 by Intellectual Property Watch 1 Comment

Infojustice.org reports: A draft report by the Australian Productivity Commission (APC) concludes that the current copyright law fails to properly balance the interests of copyright holders and users. It warns that “Australia’s copyright arrangements are weighed too heavily in favour of copyright owners, to the detriment of the long-term interests of both consumers and intermediate users.” The APC makes recommends changes to the law to address the imbalance, including “the introduction of a broad, principles-based fair use exception.”

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Copyright Policy, Information and Communications Technology/ Broadcasting, Outside Sources, Regional Policy

Wired – UNICEF Invests $9m In ‘Open Source’ Tech To Save Children’s Lives

03/02/2016 by Intellectual Property Watch 1 Comment

The United Nations will fund 60 startups to create open source technologies to improve the lives of children in developing countries. Unicef, the children’s charity run by the UN, will channel more than $9 million into startups based on venture capital-style investing. But it isn’t concerned if the companies fail.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Information and Communications Technology/ Broadcasting, Innovation/ R&D, Outside Sources, United Nations - other

The Conversation – Netflix’s VPN Ban Proves We Need To Develop A Global, Legal Digital Marketplace

03/02/2016 by Intellectual Property Watch 1 Comment

In mid-January, Netflix announced a ban on the use of proxies, unblockers, and virtual private networks (VPNs)—all technical work-arounds to view movies and TV programs unavailable in the subscriber’s country. This announcement coincided with the company’s global service launch into more than 130 new markets.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, North America, Outside Sources, Regional Policy, WIPO

Unease Over Seconded Philanthropic Foundation Staff To Top Management At WHO

15/12/2015 by Intellectual Property Watch, Intellectual Property Watch 1 Comment

Third World Network reports: Philanthropic foundations such as the Bill & Melinda Gates Foundation and the United Nations Foundation have seconded their staffers to top management positions at the World Health Organization.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Lobbying, Outside Sources, Patents/Designs/Trade Secrets, WHO

17 Year Exemption From Pharmaceutical Patents Agreed At WTO – TWN

03/11/2015 by Intellectual Property Watch, Intellectual Property Watch 1 Comment

From Third World Network: London, 3 Nov (Sangeeta Shashikant) ­ The United States and the Least Developed Countries (LDCs) at the World Trade Organization have reached agreement ad referendum on a pharmaceutical patent exemption for a duration of 17 years, according to trade diplomats.

Filed Under: IP Policies, Language, Themes, Venues, Enforcement, English, Health & IP, Human Rights, Outside Sources, Patents/Designs/Trade Secrets, WTO/TRIPS

  • 1
  • 2
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting